Antimicrobial Resistance in Neonatal and Pediatric Hospital-Onset Bloodstream Infections: Evidence from Neonatal Units and Community Comparators

Bloodstream infection (BSI) is a major cause of morbidity and mortality in neonates and children. This narrative review examines antimicrobial resistance (AMR) in pediatric BSI, with an emphasis on neonatal and hospital-onset infection. The literature was updated through 1 September 2026, using PubMed-indexed records and institutional guidance. Evidence was interpreted by age, infection setting, study design, and microbiological denominator. European and community-acquired cohorts show that pathogen distribution and resistance vary with age, care setting, and previous healthcare exposure. Extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales limit empirical treatment options in several neonatal units. Observational data link discordant empirical therapy with higher mortality, although severity and healthcare exposure may confound this association. Differences in sampling, susceptibility testing, and surveillance coverage prevent a reliable comparison of global pediatric BSI trends. Candida auris is considered separately because colonization, invasive infection, and healthcare transmission require different responses. Priorities include obtaining adequate blood cultures, selecting empirical therapy based on age- and unit-specific susceptibility data, and promptly reviewing treatment when results become available. Harmonized surveillance and pediatric treatment studies are needed to determine which approaches improve clinical outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-18
DOI
https://doi.org/10.3390/jcm15229047
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antimicrobial Resistance in Neonatal and Pediatric Hospital-Onset Bloodstream Infections: Evidence from Neonatal Units and Community Comparators

Ebrahim Abdelfattah Alkashlan, Eman S. Sawan, Shimaa Elwardany Aly, Amira A. Elhoufey et al.
Journal of Clinical Medicine
Antibiotic Resistance in Bacteria
article

Antimicrobial Resistance in Neonatal and Pediatric Hospital-Onset Bloodstream Infections: Evidence from Neonatal Units and Community Comparators

Ebrahim Abdelfattah Alkashlan, Eman S. Sawan, Shimaa Elwardany Aly, Amira A. Elhoufey, Khaled Saad, Mohamad-Hani Temsah, Mohammad Elkossi, Walaa A. Afifi, Atef A. Alkhateb, Engy Wahsh
article en

Abstract

Bloodstream infection (BSI) is a major cause of morbidity and mortality in neonates and children. This narrative review examines antimicrobial resistance (AMR) in pediatric BSI, with an emphasis on neonatal and hospital-onset infection. The literature was updated through 1 September 2026, using PubMed-indexed records and institutional guidance. Evidence was interpreted by age, infection setting, study design, and microbiological denominator. European and community-acquired cohorts show that pathogen distribution and resistance vary with age, care setting, and previous healthcare exposure. Extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales limit empirical treatment options in several neonatal units. Observational data link discordant empirical therapy with higher mortality, although severity and healthcare exposure may confound this association. Differences in sampling, susceptibility testing, and surveillance coverage prevent a reliable comparison of global pediatric BSI trends. Candida auris is considered separately because colonization, invasive infection, and healthcare transmission require different responses. Priorities include obtaining adequate blood cultures, selecting empirical therapy based on age- and unit-specific susceptibility data, and promptly reviewing treatment when results become available. Harmonized surveillance and pediatric treatment studies are needed to determine which approaches improve clinical outcomes.

Journal of Clinical MedicineVol. 15(22)
Al-Ahliyya Amman University (JO), Yanbu University College (SA), Al-Azhar University (EG), Taibah University (SA), King Saud University (SA), Stepping Hill Hospital (GB), Badr University in Cairo (EG), October 6 University (EG), Assiut University (EG), Jazan University (SA)
King Saud University
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon